Trial Profile
A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Dec 2023
Price :
$35
*
At a glance
- Drugs Tramiprosate (Primary)
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Sponsors BELLUS Health
- 10 Nov 2015 According to a BELLUS media release, the subgroup analysis from this trial was presented at 8th Clinical Trials on Alzheimers Disease Congress in Barcelona, Spain, held November 5-7, 2015.
- 06 Jul 2009 Volumetric MRI results have been published in the Journal of Nutrition, Health and Aging, according to a BELLUS media release.
- 26 Aug 2007 Status changed from in progress to completed.